These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3905414)

  • 1. The pharmacokinetics and haemodynamics of BTS 49 465 and its major metabolite in healthy volunteers.
    Wynne RD; Crampton EL; Hind ID
    Eur J Clin Pharmacol; 1985; 28(6):659-64. PubMed ID: 3905414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers.
    Cowley AJ; Wynne RD; Hampton JR
    J Hypertens Suppl; 1984 Dec; 2(3):S547-9. PubMed ID: 6599715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers.
    Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine.
    Hardy BG; Bartle WR; Myers M; Bailey DG; Edgar B
    Br J Clin Pharmacol; 1988 Nov; 26(5):557-62. PubMed ID: 3207560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of flosequinan (BTS 49465) in untreated moderate to severe hypertension.
    Janssen MC; Smits P; Reyenga J; Thien T
    J Hum Hypertens; 1995 May; 9(5):363-8. PubMed ID: 7623374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug.
    Rau R; Hind ID; Wynne RD; White SA
    Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BTS 49465 on hypoxic pulmonary vasoconstriction.
    Smith JG; Kinasewitz GT
    J Cardiovasc Pharmacol; 1986; 8(4):878-84. PubMed ID: 2427832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects.
    Clifton GD; Harrison MR; Wermeling DP; Long RA; Fleck RJ; Rolleri RL; Weller S; Brown AR; Welch RM
    Clin Pharmacol Ther; 1994 Jan; 55(1):55-63. PubMed ID: 8299318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers.
    Wolf DL; Ferry JJ; Hearron AE; Froeschke MO; Luderer JR
    Eur J Clin Pharmacol; 1993; 44(1):27-33. PubMed ID: 8436151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
    Sim MF; Yates DB; Parkinson R; Cooling MJ
    Br J Pharmacol; 1988 Jun; 94(2):371-80. PubMed ID: 3293682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes.
    Kelso EJ; McDermott BJ; Silke B
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):376-86. PubMed ID: 7769801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
    Persson B; Granerus G; Wysocki M; Hedner T; Andersson OK
    Eur J Clin Pharmacol; 1987; 31(5):513-8. PubMed ID: 2881788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.
    Cowley AJ; Wynne RD; Stainer K; Fullwood L; Rowley JM; Hampton JR
    BMJ; 1988 Jul; 297(6642):169-73. PubMed ID: 3044507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of flosequinan in patients with compromised renal function.
    Gallo BV; Hinson JL; Weidler DJ
    J Pharm Sci; 1993 Mar; 82(3):282-5. PubMed ID: 8450423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic studies in normal volunteers with MDL-899, a new arteriolar vasodilator.
    Howden CW; Elliott HL; Lawrie CB; Reid JL
    J Cardiovasc Pharmacol; 1983; 5(4):552-6. PubMed ID: 6193350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.
    Sluiter HE; Huysmans FT; Thien TA; van Lier HJ; Koene RA
    Drugs; 1985; 29 Suppl 2():26-35. PubMed ID: 2985351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
    Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.